Hamps Bio Ltd
Hamps Bio Ltd (HAMPS) last reported results for the quarter ended Mar 2026, with sales of ₹4.48 crore and net profit of ₹-0.54 crore. The stock last traded at ₹25.4, a market capitalisation of ₹22.2 crore. Over the past 52 weeks the stock has ranged between ₹13.4 and ₹26.6. Figures are as of 6 Oct 2026 and are not real time.
Hamps Bio Ltd share price and key metrics
- Current price
- ₹25.4
- Market cap
- ₹22.2 cr
- Book value
- ₹9.3
- ROE
- -8.76%
- ROCE
- -3.36%
- Dividend yield
- 0.00%
- 52w high / low
- 26.6/13.4
Metrics as of 6 Oct 2026. Not real time.
Track Hamps Bio Ltd
Cruxal reads every Hamps Bio Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Hamps Bio Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 27%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -347%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 21%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- -9%
Hamps Bio Ltd quarterly results
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 3.13 | 4.48 |
| Expenses | 2.91 | 4.62 |
| Operating profit | 0.22 | -0.14 |
| OPM % | 7.03% | -3.12% |
| Other income | 0.07 | 0.29 |
| Interest | 0.06 | 0.14 |
| Depreciation | 0.19 | 0.51 |
| Profit before tax | 0.04 | -0.5 |
| Tax % | 25.00% | 6.00% |
| Net profit | 0.03 | -0.54 |
| EPS (₹) | 0.03 | -0.62 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Hamps Bio Ltd annual results
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 6.67 | 8.46 |
| Operating profit | 0.77 | 0.04 |
| OPM % | 11.54% | 0.47% |
| Net profit | 0.3 | -0.74 |
| EPS (₹) | 0.34 | -0.85 |
TTM is the trailing twelve months to the most recent quarter.
Hamps Bio Ltd balance sheet
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 4.36 | 8.71 |
| Reserves | 4.44 | -0.61 |
| Borrowings | 2.97 | 6.89 |
| Other liabilities | 1.02 | 0.93 |
| Total liabilities | 12.79 | 15.92 |
| Fixed assets | 2.48 | 9.10 |
| CWIP | 3.38 | 1.08 |
| Investments | 0.00 | 0.07 |
| Other assets | 6.93 | 5.67 |
| Total assets | 12.79 | 15.92 |
As reported by the company. Total assets equal total liabilities by construction.
Hamps Bio Ltd cash flow
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operations | -1.76 | -0.71 |
| Cash from investing | -6.21 | -2.93 |
| Cash from financing | 8.00 | 3.72 |
| Net cash flow | 0.04 | 0.07 |
| Free cash flow | -5.48 | -5.84 |
| CFO / operating profit | -214% | -1,775% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Hamps Bio Ltd operating ratios
| Per year | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | — | -3.36% |
| Debtor days | 65.12 | 68.60 |
| Inventory days | 434.35 | 298.01 |
| Days payable | 109.50 | 39.27 |
| Cash conversion cycle | 389.97 | 327.33 |
| Working capital days | 128.05 | 65.15 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Hamps Bio Ltd shareholding pattern
Promoters held 71.99% at Mar 2026, broadly unchanged since Dec 2024. FIIs 0.00% and DIIs 0.00%.
| % held | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoters | 71.99% | 71.99% | 72.00% | 71.99% |
| FIIs | 0.18% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.05% | 0.00% | 0.00% | 0.00% |
| Public | 27.78% | 28.01% | 28.01% | 28.01% |
| No. of shareholders | 589 | 410 | 395 | 395 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Hamps Bio Ltd corporate filings
- Closure of Trading Window for declaration of Unaudited Standalone and Consolidated financial results for the half year ending on September 30, 2026.Insider Trading / SASTlow impact
- Hamps Bio Limited Announces Successful Conclusion of 19th Annual General Meeting and Approval of Key ResolutionsAGM/EGMlow impact
Cruxal's analysis: Hamps Bio Limited has successfully concluded its 19th Annual General Meeting held on…
Read the full analysis - Hamps Bio Ltd. Announces Remuneration Hikes for Key Management PersonnelOtherslow impact
Cruxal's analysis: Hamps Bio Ltd. has announced an increase in remuneration for its Chairman and Managing…
Read the full analysis - Hamps Bio Limited Concludes 19th Annual General Meeting; Proposes Registered Office RelocationAGM/EGMlow impact
Cruxal's analysis: Hamps Bio Limited has successfully concluded its 19th Annual General Meeting held on…
Read the full analysis - Hamps Bio Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Hamps Bio Ltd has filed its Annual Report for the financial year 2025-26. The report…
Read the full analysis - Hamps Bio Limited Announces 19th Annual General Meeting and Proposed Registered Office ShiftAGM/EGMlow impact
Cruxal's analysis: Hamps Bio Limited has issued a notice for its 19th Annual General Meeting (AGM) scheduled…
Read the full analysis - Hamps Bio Ltd. Announces 19th AGM for September 9, 2026, and Proposes Registered Office Shift to SuratOtherslow impact
Cruxal's analysis: Hamps Bio Ltd. has announced its 19th Annual General Meeting (AGM) scheduled for…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.